Adenoid cystic carcinoma (ACC) is a rare salivary glands tumor and often displays
aggressive behavior with frequent relapse and metastasis. The terminal ACC lacks standard …

TPS6597 Background: Adenoid cystic carcinoma (ACC) is a rare salivary gland malignancy,
also found in other secretory gland sites (tracheobronchial tree, esophagus, breast, lungs …

6026 Background: There is no specific therapy, including targeted agents, has consistently
improved clinical outcomes in recurrent/metastatic adenoid cystic carcinoma of the head and …

PURPOSE Recurrent or metastatic adenoid cystic carcinoma (R/M ACC) is a malignant
neoplasm of predominantly salivary gland origin for which effective therapies are lacking …

Background Adenoid cystic carcinoma (ACC) of the salivary gland frequently develops lung
metastases. In cases in which chemotherapy is indicated, resistance is a common …

Introduction Adenoid cystic carcinoma (ACC) of the head and neck is a rare malignancy of
the salivary glands that accounts for approximately 10% of salivary gland carcinoma …

6086 Background: Systemic chemotherapy and targeted therapies (TT) are almost
ineffective in R/M ACC patients (pts). Sorafenib and axitinib showed some activity, possibly …

Background There is a need to improve the systemic treatment of advanced adenoid cystic
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …

6026 Background: There is no standard treatment for recurrent/metastatic adenoid cystic
carcinoma of the head and neck (R/M ACCHN). Moreover, MYB and/or NOTCH1 mutation …

Adenoid cystic carcinoma (ACC) is a rare malignant tumor derived mainly from the salivary
glands, representing approximately 1% of all head and neck carcinomas and 10% of all …